Yuyu Pharma, Inc.

Symbol: 000225.KS

KSC

6380

KRW

company-market-status

  • -51.4872

    P/E ratio

  • 0.0000

    PEG ratio

  • 60.86B

    Mrk Cap

  • 0.02%

    Div Yield

Yuyu Pharma, Inc. (000225-KS) Stock Split, History Data

Оборотен капитал

Всички числа в милиони

202220212020201920182017
Парични средства и инвестиции25838.5850263.4720322.8226846.2326966.5519812.44
Приемници0.000.000.000.000.000.00
Инвентарна книга39832.0425225.2823688.8917015.9815615.9619593.38
Други439.30493.98426.45114.22225.190.00
Общо текущи активи96357.7598887.9264466.5565053.8968869.6663470.37
Acc Payable15840.538982.265286.766385.095056.818453.25
Краткосрочен дълг37424.9610427.314978.1623872.4712366.2018070.00
Други текущи пасиви11050.0410605.178133.7812238.0710364.568960.39
Текущи пасиви64315.5330014.7518398.7042495.6327787.5735483.64

Капиталова структура

Всички числа в милиони

Общо активи

196576,56 щ.д.

Общо активи

196576561000,00 щ.д.

Общо задължения

75838,64 щ.д.

Общо задължения

75838637000,00 щ.д.

Дългосрочен дълг

2402,39 щ.д.

Дългосрочен дълг

2402389000,00 щ.д.

Парични средства и екви

24675,92 щ.д.

Парични средства и екви

24675923410,00 щ.д.

Goodwill

50,83 щ.д.

Goodwill

50829000,00 щ.д.

Неразпределена печалба

29199,26 щ.д.

Неразпределена печалба

29199259860,00 щ.д.

Обикновени акции

6208,29 щ.д.

Обикновени акции

6208290000,00 щ.д.

Стойност на предприятието

0,00 щ.д.

Дивиденти за маса

Подзаглавие на таблицата Dividends

ГодиниQ1Q2Q3Q4Общо
2006115.0000.0000.0000.000115.000
2007125.0000.0000.0000.000125.000
2008155.0000.0000.0000.000155.000
200940.0000.0000.0000.00040.000
201045.0000.0000.0000.00045.000
201155.0000.0000.0000.00055.000
201265.0000.0000.0000.00065.000
201385.0000.0000.0000.00085.000
201495.0000.0000.0000.00095.000
201595.0000.0000.0000.00095.000
201695.0000.0000.0000.00095.000
201795.0000.0000.000100.000195.000
20180.0000.0000.000105.000105.000
20190.0000.0000.000110.000110.000
20200.0000.0000.000110.000110.000
20210.0000.0000.000110.000110.000
20220.0000.0000.000110.000110.000

Печалба на акция

Подзаглавие "Доходи на акция

ГодиниQ1Q2Q3Q4Общо
2006115.0000.0000.0000.000115.000
2007125.0000.0000.0000.000125.000
2008155.0000.0000.0000.000155.000
200940.0000.0000.0000.00040.000
201045.0000.0000.0000.00045.000
201155.0000.0000.0000.00055.000
201265.0000.0000.0000.00065.000
201385.0000.0000.0000.00085.000
201495.0000.0000.0000.00095.000
201595.0000.0000.0000.00095.000
201695.0000.0000.0000.00095.000
201795.0000.0000.000100.000195.000
20180.0000.0000.000105.000105.000
20190.0000.0000.000110.000110.000
20200.0000.0000.000110.000110.000
20210.0000.0000.000110.000110.000
20220.0000.0000.000110.000110.000
Подобни запаси
Може да се интересувате и от
CHSYF
China Medical System Holdings Limited.
1.381 USD
PNK
DHT-UN.TO
DRI Healthcare Trust.
10.22 CAD
TSX
RMTI
Rockwell Medical, Inc..
4.55 USD
NASDAQ
BOD.AX
Bod Science Limited.
0.047 AUD
ASX
AVCN.TO
Avicanna Inc..
0.31 CAD
TSX
600664.SS
Harbin Pharmaceutical Group Co., Ltd..
3.53 CNY
SHH
PDPL.NS
Parenteral Drugs (India) Limited.
4 INR
NSE
SCYX
SCYNEXIS, Inc..
2.76 USD
NASDAQ
001360.KS
SAMSUNG PHARM. Co., LTD..
3240 KRW
KSC

Frequently Asked Question

Why is your stock tool better than competitors?

Numfin provides most features for free and gives you accurate and expert data about public companies. We also offer unique features like AI copilot that are not found on other platforms

Can I trust the data on your website and where do they come from?

Absolutely. We receive the data from our partners and other official sources, such as popular stock exchanges (NASDAQ, NYSE, and others), SEC.gov, and other official platforms. Our data provider, FinancialModeling, also provides information for portals like Moody's, Harvard, Chevron, and others. All this proves the accuracy and authority of the information.

Who creates the content on your website and is it approved by experts in finance and investing?

All financial data is received from our data provider and then verified by industry experts. Additionally, we use various AI tools like ChatGPT to present content in a user-friendly and well-structured manner.

What problem does your tool solve? Who is the target audience for your tool

Our main goal is to present accurate and expert information about public companies in a structured manner. We work with investors and financial professionals who have a long-term outlook. Our community consists of private investors, business owners, stock analysts, fund managers, and people who are interested in investing.

Why did you decide to create your tool?

While managing our own money, we searched for the best analytical tool to help us better analyze public companies. Most websites that provided analytics for professional investors were expensive, and the cheap tools were either limited in functionality or lacked valuable company data. Even worse, some of them presented incorrect numbers. As a result, we combined our experience in business, IT, and finance to create the most affordable and useful solution for investors and anyone interested in finance and stock analysis.

What is the difference between free and paid options? Should I buy Pro version from start or it's ok to have a free version?

Most features on our website are free so that many people can use it to analyze companies on the world's top stock exchanges. However, some features, such as our artificial intelligence chat, advanced analytics, filters, and storing of vast historical data, require additional servers from our end. Therefore, we rely on your support to keep this amazing project running. If you would like to experience the full potential of our service, we strongly recommend that you purchase the PRO version, which comes with a 30-day money-back guarantee

Who is your team and do they have enough experience?

You can read about our team here, or you can contact us at [email protected] for more information.